We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance for Defibrillator Distribution

By HospiMedica staff writers
Posted on 13 Aug 2002
Print article
A distribution agreement has been announced by Zoll Medical Corp. (Burlington, MA, USA) whereby the company's defibrillators will be marketed to targeted European markets through the sales channels of Draeger Medical AG (Lubeck, Germany).

The products to be marketed by Draeger include the M Series defibrillator, targeted to the traditional hospital and emergency medicine (EM) markets, as well as the company's new first responder defibrillator, the automatic external defibrillator (AED) called AED Plus. Both platforms include Zoll's proprietary rectilinear biphasic waveform, which Zoll says offers significant clinical benefits.

"The cooperation enables us to complete our portfolio in emergency care, which currently consists of emergency and transport ventilation systems,” said Dr. M.Th.A. Teeling, general manager, Pre & Post Hospital Care, Draeger Medical. "Customers will benefit from the combination of two highly innovative product lines and expertise from one source.”

"Between Draeger's sizable market penetration, name recognition, and proven sales and service network worldwide, we anticipate this partnership will contribute to our expanding presence in European markets,” said Ronald Melieste, director of European operations, Zoll Medical.




Related Links:
Zoll
Draeger
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
LED Phototherapy System
neoBLUE compact
New
Fixed Volume Dispense Pump
LPL Series

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.